Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ...
Research analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Vir Biotechnology in a ...
Leerink Partners analyst Roanna Ruiz reiterated a Buy rating on Vir Biotechnology (VIR – Research Report) on January 13 and set a price target ...
Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Vir Biotechnology (VIR – Research Report) yesterday and set a ...
Vir Biotechnology Inc (VIR) stock saw a decline, ending the day at $12.1 which represents a decrease of $-0.38 or -3.04% from the prior close of $12.48. The stock opened at $12.69 and touched a low of ...
Dr Rajesh Gupta, vice president, global health portfolio and public-private partnerships at Vir Biotechnology, said: “COVID-19 reinforced the ever-present global threat of infectious diseases ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
With new legislation and noteworthy policies on sci-tech and innovation expected this year, businesses are hoping the right ...
China Medical University and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel ...
WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security ...
A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...